Abstract:Purpose: OptiSafeTM (OS) is a shelf stable, nonanimal test for ocular irritation. A recent database search found that half of the OS false positive (FP) materials were associated with reactive oxygen chemistries but were not eye irritants in vivo (based on historical rabbit studies by other groups). We hypothesized that naturally occurring tear antioxidants protect the eye from reactive chemistries in vivo and that specific tear chemistries might help explain why some materials are FP for nonanimal tests but are reported as nonirritants in the live animal. To test this hypothesis, a prior study evaluated tear antioxidants and found that the tear antioxidant ascorbic acid, added at human physiological tear levels to the OS test, specifically reduced the measured values for these FPs but did not reduce the true-positive rate. Based on these findings, the OS test method was further optimized. The purpose of the current study was to comprehensively evaluate the performance of the further optimized test method for detection of ocular irritants. Materials and methods: The OS test measures chemically induced damage to macromolecules and relates these measured values to ocular irritancy. To improve the performance of OS, we made updates to the material to be tested physiochemical handling procedures, prediction model, and test method to include tear-level concentrations of ascorbic acid. We then retested the 78 chemicals from the prior OS-coded validation study in triplicate and compared the accuracy of the 'nonirritant versus irritant' prediction for the further optimized method with the prior results. Results: We report that for the detection of 'nonirritant' versus 'irritant' (GHS NC versus categories 2B/A and 1) test substances, the further optimized OS test with ascorbic acid compared with the original version has a FP rate that is reduced from 40.0 to 22.2%, the false-negative (FN) rate remains at 0.0%, and the accuracy improved from 80.3% to 89.2%. Conclusion: A comparison to OECD-adopted tests demonstrates that the further optimized OS test, like the original method, has a higher accuracy and lower FN rate for the detection of 'nonirritants' versus 'irritants' (GHS Category NC versus 2B/A and 1) than the other eye irritation tests (BCOP, EpiOcularTM Eye Irritation Test, ICE, Ocular Irritection®, and STE).

Amino acid derivative reactivity assay–organic solvent reaction system: A novel alternative test for skin sensitization capable of assessing highly hydrophobic substances

Oxidation of a cysteine-derived nucleophilic reagent by dimethyl sulfoxide in the amino acid derivative reactivity assay

The within‐ and between‐laboratory reproducibility and predictive capacity of the in chemico amino acid derivative reactivity assay: Results of validation study implemented in four participating laboratories

The underlying factors that explain why nucleophilic reagents rarely co-elute with test chemicals in the ADRA

Borderline Range Determined Using Data From Validation Study of Alternative Methods for Skin Sensitization: ADRA, IL‐8 Luc Assay, and EpiSensA

Development of an in chemico high-throughput screening method for the identification of skin sensitization potential

Performance of the DASF compared to other combinations of OECD NAMs for eye hazard identification of surfactants

Proteomic allergen-peptide/protein interaction assay for the identification of human skin sensitizers

Development of a peptide reactivity assay for screening botanicals and natural substances: Proof of concept studies

Integrated skin sensitization assessment based on OECD methods (II): Hazard and potency by combining kinetic peptide reactivity and the "2 out of 3" Defined Approach

Development of a novel in vitro respiratory sensitization assay and its application in an integrated testing strategy (ITS)

Evaluation of a New In Chemico Skin Corrosion Test

Research of a SPR Immunoassay Method for Okadaic Acid Contamination of Red Tide Toxins

GARDskin dose-response assay and its application in conducting Quantitative Risk Assessment (QRA) for fragrance materials using a Next Generation Risk Assessment (NGRA) framework

Application of direct peptide reactivity assay for assessing the skin sensitization potential of essential oils

An epidermal equivalent assay for identification and ranking potency of contact sensitizers

Limitations and Modifications of Skin Sensitization NAMs for Testing Inorganic Nanomaterials

Increasing Accessibility of Bayesian Network-Based Defined Approaches for Skin Sensitisation Potency Assessment

Further optimisation of a macromolecular ocular irritation test (OptiSafeTM)

Skin Sensitization Potency Prediction Based on Read‐Across (RAx) Incorporating RhE‐Based Testing Strategy (RTSv1)–Defined Approach: RTSv1‐Based RAx

Improved performance of the SH test as an in vitro skin sensitization test with a new predictive model and decision tree